Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog commonly studied for its role in growth hormone signaling, metabolic activity, and body composition support.
Unlike broader growth hormone secretagogues, Tesamorelin stands out for its strong association with visceral adipose tissue pathways, making it a compound of particular interest in research focused on stubborn fat storage around internal organs, metabolic efficiency, and overall body composition changes.
By stimulating natural growth hormone release through targeted pituitary signaling, Tesamorelin helps drive downstream pathways linked to lipid metabolism, recovery, tissue maintenance, and energy utilization.
Frequently studied for its role in reducing visceral adipose tissue (fat stored around internal organs) while improving overall body composition
Stimulates natural growth hormone release through targeted growth hormone-releasing hormone (GHRH) signaling
Supports metabolic function and lipid metabolism pathways to utilize energy and support body composition
Helps preserve lean muscle tissue
Investigated for recovery support, cellular repair processes, and downstream growth hormone activity
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that interacts with pituitary receptors to trigger natural growth hormone release.
Once activated, this signaling helps stimulate pulsatile growth hormone secretion, which can influence downstream pathways tied to fat metabolism, tissue repair, recovery, and overall metabolic function.
What makes Tesamorelin unique is its stronger association with visceral fat pathways compared to more general growth hormone support compounds, making it especially relevant in body composition-focused research
Compound Type: Synthetic Hormone Analog
Classification: Growth Hormone Releasing Hormone (GHRH) Analog
Primary Structure: 44 Amino Acid Synthetic compound
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: ~5135.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Form: Lyophilized Powder
Administration Route: Subcutaneous
Stability Profile: Lyophilized compound; stable under recommended cold storage conditions prior to reconstitution. Reconstituted stability depends on storage conditions and handling.
Development Status: FDA-approved active pharmaceutical ingredient originally developed for visceral adipose tissue reduction research and metabolic applications
Research Application: Growth hormone signaling, metabolic pathway analysis, visceral fat studies, lipid metabolism pathways, recovery and body composition research
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog commonly studied for its role in growth hormone signaling, metabolic activity, and body composition support.
Unlike broader growth hormone secretagogues, Tesamorelin stands out for its strong association with visceral adipose tissue pathways, making it a compound of particular interest in research focused on stubborn fat storage around internal organs, metabolic efficiency, and overall body composition changes.
By stimulating natural growth hormone release through targeted pituitary signaling, Tesamorelin helps drive downstream pathways linked to lipid metabolism, recovery, tissue maintenance, and energy utilization.
Frequently studied for its role in reducing visceral adipose tissue (fat stored around internal organs) while improving overall body composition
Stimulates natural growth hormone release through targeted growth hormone-releasing hormone (GHRH) signaling
Supports metabolic function and lipid metabolism pathways to utilize energy and support body composition
Helps preserve lean muscle tissue
Investigated for recovery support, cellular repair processes, and downstream growth hormone activity
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that interacts with pituitary receptors to trigger natural growth hormone release.
Once activated, this signaling helps stimulate pulsatile growth hormone secretion, which can influence downstream pathways tied to fat metabolism, tissue repair, recovery, and overall metabolic function.
What makes Tesamorelin unique is its stronger association with visceral fat pathways compared to more general growth hormone support compounds, making it especially relevant in body composition-focused research
Compound Type: Synthetic Hormone Analog
Classification: Growth Hormone Releasing Hormone (GHRH) Analog
Primary Structure: 44 Amino Acid Synthetic compound
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: ~5135.9 g/mol
Appearance: White to off-white sterile lyophilized powder
Form: Lyophilized Powder
Administration Route: Subcutaneous
Stability Profile: Lyophilized compound; stable under recommended cold storage conditions prior to reconstitution. Reconstituted stability depends on storage conditions and handling.
Development Status: FDA-approved active pharmaceutical ingredient originally developed for visceral adipose tissue reduction research and metabolic applications
Research Application: Growth hormone signaling, metabolic pathway analysis, visceral fat studies, lipid metabolism pathways, recovery and body composition research
SlimFit Compounds partners with emerging U.S.-based manufacturers that adhere to strict production, verification, and purity standards. These research-grade formulations are produced using protocols comparable to those employed by major pharmaceutical laboratories, enabling access to high-quality compounds without excessive cost barriers.
This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.
Information provided is for educational and research reference purposes only and has not been evaluated by the FDA. Only qualified professionals should handle this compound in appropriate research or laboratory settings.
